Cerebrospinal fluid levels of 3‐methoxy4hydroxyphenylethylene glycol in Parkinsonism before and after treatment with L‐DOPA¹

This publication has 16 references indexed in Scilit:

• L-Dopa: Effect on Concentrations of Dopamine, Norepinephrine, and Serotonin in Brains of Mice
  Science, 1970
• Depressed Monoamine Catabolite Levels in Cerebrospinal Fluid of Patients with Parkinsonism Dementia of Guam
  New England Journal of Medicine, 1970
• The metabolism of orally administered l‐DOPA in Parkinsonism
  British Journal of Pharmacology, 1969
• Modification of Parkinsonism — Chronic Treatment with L-Dopa
  New England Journal of Medicine, 1969
• 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndrome
  Life Sciences, 1967
• On the Occurrence of Homovanillic Acid and 5-Hydroxyindol-3-ylacetic Acid in the Ventricular C.S.F. of Patients Suffering from Parkinsonism
  Stereotactic and Functional Neurosurgery, 1967
• THE METABOLISM OF [C¹⁴]NORADRENALINE BY CAT BRAIN IN VIVO*
  Journal of Neurochemistry, 1963
• Zur Biochemie des Parkinson-Syndroms des Menschen
  Klinische Wochenschrift, 1963
• Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen Systems
  Journal of Molecular Medicine, 1960
• 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists
  Nature, 1957